Validation of the Quality Assessment Tool for Systematic Reviews and Meta-Analyses of Real-World Studies

References

[1] J. Grossman and F. J. Mackenzie, “The Randomized Controlled Trial: Gold Standard, or Merely Standard?,” Perspectives in Biology and Medicine 48, no. 4 (2005): 516-534.

[2] F. Liu and D. Panagiotakos, “Real-World Data: A Brief Review of the Methods, Applications, Challenges and Opportunities,” BMC Medical Research Methodology [Electronic Resource] 22, no. 1 (2022): 287.

[3] O. Cavlan, S. Chilukuri, M. Evers, and A. Westra, Real-World Evidence: From Activity to Impact in Healthcare Decision Making (McKinsey & Company, 2018).

[4] D. Chen, “Real-World Studies: Bridging the Gap Between Trial-Assessed Efficacy and Routine Care,” J Biomed Res 36, no. 3 (2022): 147.

[5] M. H. Roberts and G. T. Ferguson, “Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions,” PharmacoEconomics Open 5 (2021): 3-11, https://doi.org/10.1007/s41669-020-00221-y.

[6] L. Azoulay, “Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective,” The Oncologist 27, no. 9 (2022): e731-e738, https://doi.org/10.1093/oncolo/oyac114.

[7] S. Gopalakrishnan and P. Ganeshkumar, “Systematic Reviews and Meta-Analysis: Understanding the Best Evidence in Primary Healthcare,” Journal of Family Medicine and Primary Care 2, no. 1 (2013): 9-14.

[8] NICE, National Institute for Health and Care Excellence—NICE Real-World Evidence Framework (2022), accessed Nov 21, 2024, https://www.nice.org.uk/corporate/ecd9/chapter/overview.

[9] S. Y. Kim, J. E. Park, Y. J. Lee, et al., “Testing a Tool for Assessing the Risk of Bias for Nonrandomized Studies Showed Moderate Reliability and Promising Validity,” Journal of Clinical Epidemiology 66, no. 4 (2013): 408-414.

[10] T. Gebrye, F. Fatoye, C. Mbada, and Z. Hakimi, “A Scoping Review on Quality Assessment Tools Used in Systematic Reviews and Meta-Analysis of Real-World Studies,” Rheumatology International 43, no. 9 (2023): 1573-1581.

[11] T. Gebrye, C. Mbada, Z. Hakimi, and F. Fatoye, “Development of Quality Assessment Tool for Systematic Reviews and Meta-Analyses of Real-World Studies: A Delphi Consensus Survey,” Rheumatology International 44 (2024): 1-7.

[12] A. Królikowska, P. Reichert, J. Karlsson, C. Mouton, R. Becker, and R. Prill, “Improving the Reliability of Measurements in Orthopaedics and Sports Medicine,” Knee Surgery, Sports Traumatology, Arthroscopy 31, no. 12 (2023): 5277-5285.

[13] J. M. Bland, “Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement,” Lancet 1, no. 8476 (1986): 307-310.

[14] T. K. Koo and M. Y. Li, “A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research,” Journal of Chiropractic Medicine 15, no. 2 (2016): 155-163.

[15] B. J. Shea, C. Hamel, G. A. Wells, et al., “AMSTAR Is a Reliable and Valid Measurement Tool to Assess the Methodological Quality of Systematic Reviews,” Journal of Clinical Epidemiology 62, no. 10 (2009): 1013-1020.

[16] P. Juni, “Assessing the Quality of Controlled Clinical Trials,” Bmj 323, no. 7303 (2001): 42-46.

[17] D. E. Barnes, “Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions,” Jama 279, no. 19 (1998): 1566-1570.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.